Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Abstract Background The sensitivity and specificity of minimal residual disease detected by circulating tumor DNA profiling (ctDNA MRD) in lung cancer, with particular attention to the distinction between landmark strategy and surveillance strategy, for predicting relapse in lung cancer patients aft...
Main Authors: | Ran Zhong, Rui Gao, Wenhai Fu, Caichen Li, Zhenyu Huo, Yuewen Gao, Yi Lu, Feng Li, Fan Ge, Hengjia Tu, Zhixuan You, Jianxing He, Wenhua Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-023-02849-z |
Similar Items
-
Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review
by: Lemei Zhu, et al.
Published: (2023-08-01) -
Network approach in liquidomics landscape
by: Daniele Santini, et al.
Published: (2023-08-01) -
Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
by: Xiaoxu Fang, et al.
Published: (2022-10-01) -
The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01) -
Epigenetic liquid biopsies for minimal residual disease, what’s around the corner?
by: Andrew D. Johnston, et al.
Published: (2023-04-01)